Open

Enforcing Sanctions on China and Russia - DFOP0017256

Request Ticket // Limit: 1 // Tickets Available: 1

Eligibility
Applicants can submit one application in response to the NOFO.  If more than one application is submitted by an organization, only the final application received, and time stamped by grants.gov will be reviewed for eligibility.  Each application can include multiple projects that will be evaluated independently. 

Executive Summary 
China and Russia systematically exploit global supply chains and the U.S. financial system to acquire proliferation-sensitive goods and technologies and support onward proliferation through illicit trade networks. These actions are in violation of U.S. and international laws and regulations and undermine American security and prosperity and the security of our partners and allies.   

ISN/CTR conducts global national security programming that counters illicit procurement, investment schemes, and financing networks that China and Russia use to exploit international trade and finance.  U.S. and partner country sanctions and economic deterrents target the nodes and sectors that enable China’s & Russia’s military modernization and sanctions evasion efforts; however, these tools are only as strong as their implementation and enforcement around the globe. 

ISN/CTR provides partners with enhanced capabilities to identify and disrupt complex sanctions evasion strategies and understand the risks of noncompliance (e.g. potential secondary sanctions). ISN/CTR accomplishes this through technical engagements that provide resources to assist partners to identify and avoid transactions with designated entities, and their associated networks. Engagements are tailored to discrete audiences within the public and private sector and address region or jurisdiction-specific issues.

 

Research Category
Funding Type
Internal Deadline
External Deadline
7/30/2025
Solicitation Type

DFOP0017248 - Preventing U.S. Adversaries’ Access to Critical Technologies and Exploitation of Scientific and Commercial Facilities for Military Advancement

Request Ticket // Limit: 1 // Tickets Available: 1

Eligibility
Applicants can submit one application in response to the NOFO.  If more than one application is submitted by an organization, only the final application received, and time stamped by grants.gov will be reviewed for eligibility.  Each application can include multiple projects that will be evaluated independently. 

Executive Summary
U.S. adversaries, including China, are seeking advanced and emerging technologies to advance their military capabilities and to develop and deploy weapons of mass destruction (WMD) and advanced conventional weapons against the United States.  A significant number of foreign governments, public and private research organizations, tech industries, and start-up communities are unaware of dual-use applications of technologies and remain vulnerable to theft and loss of technologies, data, intellectual property (IP), knowledge and talent that can be leveraged for military end uses.  For example, semiconductors, which are critical components in a most of today’s electronic devices, are also a critical input for the development of military technologies, WMD and WMD delivery systems, and technologies with potential dual-uses – such as artificial intelligence.  In addition to seeking advanced technologies, adversaries exploit commercial and scientific facilities, training centers, and the seas to conduct illegal military operations.

Malign actors use legal and illegal means such as joint commercial ventures, talent recruitment programs, research partnerships/funding, predatory contracting agreements, private equity investments, joint scientific facilities/laboratories, cybertheft, state-sponsored industrial espionage, supply chain diversion, or sales or donation of untrusted hardware and software to acquire foreign intellectual property, conduct dual-use research and development, or conduct military activities under the guise of science diplomacy or commercial activity.  Affiliations and links to military entities are often obfuscated or disguised when establishing collaborations and partnerships in order to gain admission and secure visas to study or conduct research on sensitive advanced and emerging technologies at foreign universities; to procure critical equipment and components from unsuspecting or indiscriminate commercial or scientific institutions; or when establishing joint scientific facilities or operating in international business markets. 

ISN/CTR seeks to enable key foreign partners to protect critical advanced and emerging technologies from exploitation by our adversaries for military, technological, and economic advancement; secure U.S. intellectual property (IP) abroad; and prevent the exploitation of commercial and scientific partnerships in several key areas, including but not limited to: aerospace and space technologies, artificial intelligence (AI), nanotechnologies, neuroscience, quantum computing and sensing, semiconductors, and smart cities.  ISN/CTR also seeks to apply risk reduction tools to more traditional security vulnerabilities that are exploited by proliferator states for military training, geographic influence, etc.  

Internal Deadline
External Deadline
7/30/2025
Solicitation Type

American Cybersecurity Enhancement Program for Thai Entrepreneurs - 2025

Request Ticket // Limit: 1 // Tickets Available: 1

Eligibility
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding.

Executive Summary
The U.S. Embassy Bangkok Public Diplomacy Section (PDS) is pleased to invite eligible applicants to submit program ideas to implement the American Cybersecurity Enhancement Program (ACEP) for Thai Entrepreneurs. This program will leverage American cybersecurity best practices to address the critical need for robust and adequate cybersecurity measures among businesses, startups, and small and medium-sized enterprises (SMEs) in Thailand. The program must include American elements or connections with American experts, companies, or organizations in the respective fields.

Internal Deadline
External Deadline
7/4/2025
Solicitation Type

2025 Stocker Foundation Grant

Request Ticket // Limit: 1 // Tickets Available: 1

At The Stocker Foundation, we're all about helping students from prekindergarten through eighth grade become curious lifelong learners. Our grantmaking supports 21st century reading literacy and STEAM (science, technology, engineering, arts, and math) activities that encourage kindergarten readiness, grade-level reading proficiency, creative thinking, and problem-solving skills. We believe that when all students have access to quality education, they develop a passion for learning, which paves the way for future opportunities.

In 2024, The Stocker Foundation’s Board of Trustees approved 199 grants totaling over $2 million to communities served. Our funding supports:

  • The development of foundational reading and writing skills so that students can read at or above grade level by third grade
  • Cross-disciplinary, project-based STEAM learning that connects subjects through hands-on experiences

We also set aside a small portion of our funding to help remove obstacles that might keep students from academic success.

The Stocker Foundation conducts one grant cycle annually. We welcome applications from organizations who share our passion for transforming educational opportunities for students who need them most.

Deadlines:
Stage 1 (eligibility check) - September 30, 2025
Stage 2 (application) - November 30, 2025

Research Category
Funding Type
Internal Deadline
External Deadline
9/30/2025
Solicitation Type

2025 St. Baldrick's Foundation Infrastructure Awards

Request Ticket // Limit: 1 // Tickets Available: 1

These grants are not for a specific research project, but rather for personnel (i.e., a clinical research associate) or resources to allow more research to be done. These grants are intended for institutions with the potential to participate significantly more in childhood cancer clinical trials, but which are smaller or have barriers to greater participation due to a lack of resources. Applications to support Clinical Research Associate (CRA) type positions are preferred. Preference is given to institutions with high needs and low philanthropic support in geographical areas where St. Baldrick’s funds are raised. Institutions which do not currently receive other St. Baldrick’s grants are also given preference. (Grant will be $25,000–$50,000.)  

For full eligibility criteria, please see the RFA.

Funding Type
Internal Deadline
External Deadline
7/8/2025
Solicitation Type

2026 St. Baldrick's Fellows

Request Ticket // Limit: 1* // Tickets Available: 1

* ATTENTION: limited submissions policy exception:  Due to high interest from donors and low numbers of past applications, a second Fellow application will be accepted only if focused on one of the following: 

  • Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
  • Burkitt lymphoma – all types, especially sporadic 
  • Rhabdoid tumors - Extrarenal 
     

Fellowship Duration

St. Baldrick’s Fellowships are granted for two (2) years of pediatric oncology fellowship training, with an opportunity for one (1) additional year of funding based upon need, significant accomplishment, and approved application. 

Eligibility 

For full eligibility, please see the RFA.

Funding Type
Internal Deadline
External Deadline
7/8/2025
Solicitation Type

FY 2025 Benjamin A. Gilman International Scholarship Program

Request Ticket // Limit: 1 // Tickets Available: 1

Eligibility
Only one proposal will be considered by ECA from each applicant organization. In cases where more than one submission from an applicant appears in grants.gov, ECA will only consider the submission made closest in time to the NOFO deadline; that submission would constitute the one and only proposal ECA would review from that applicant.|

Executive Summary
The U.S. Study Abroad Branch within the Office of Global Educational Programs of the Bureau of Educational and Cultural Affairs (ECA) announces an open competition to administer the FY2025 Benjamin A. Gilman International Scholarship Program (hereinafter referred to as the “Gilman Program”). The stated intent of the International Academic Opportunity Act of 2000, the authorizing legislation for the Gilman Program, is to support U.S. undergraduate students of limited financial means to study outside the United States in order to “broaden the outlook and better prepare such students of demonstrated financial need to assume significant roles in the increasingly global economy.” As outlined in legislation, the Gilman Program is open to citizens and nationals of the United States and provides scholarships to enable undergraduate students of limited financial means to pursue credit-bearing academic studies or internships overseas.

Research Category
Internal Deadline
External Deadline
6/30/2025

2025 Macy Faculty Scholars Program

Request Ticket // Limit: 3* // Tickets Available: 3

The University of Arizona may submit a total of three nominations:

  • One from the College of Medicine - Tucson // Tickets Available: 1
  • One from the College of Medicine - Phoenix // Tickets Available: 1
  • One from the College of Nursing // Tickets Available: 0
    C. Lee (Nursing)



Eligibility:

  1. Be a benefits-eligible faculty member in a United States accredited nursing school, allopathic medical school, or osteopathic medical school. Candidates should have approximately three to eight years of faculty experience at the time of application.
  2. Be a doctorally prepared faculty member in good standing at the sponsoring school.
  3. Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school, and a nursing or medical school with a first-year Macy Faculty Scholar is precluded from nominating a candidate.
  4. Have an educational scholarship project with the appropriate institutional support.
  5. Have a faculty mentor who will advise the candidate on the candidate's educational project and career development.
  6. Have an institutional commitment for the protection of 50% of the candidate’s time.
  7. Be a citizen or permanent resident of the United States or its territories.

 

Program Overview

The Macy Faculty Scholars Program, now in its second decade, aims to identify and nurture promising early-career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses, and role models—individuals who represent the breadth of diversity seen in learners, patient populations, and health care settings around the country. By providing the Scholars with resources—especially protected time, mentorship, and a professional network of colleagues—the program aims to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally, and beyond.

This is a career development award. The Foundation is interested in candidates for whom the program will have the maximum impact at this point in their career and who also have the greatest possibility for future impact at their home institutions and beyond. Macy Faculty Scholars will participate in the Macy Faculty Scholars Annual Meeting and will be part of the family of Macy Faculty Scholars for the remainder of their careers.

In order to develop the careers of educators who are future leaders, the Macy Faculty Scholars Program will provide salary support for each Scholar up to $100,000 per year, which will protect 50% of the Scholar’s time over two years. The Scholar will devote this time to a mentored educational scholarly project and other appropriate career development activities.

Funding Type
Internal Deadline
External Deadline
8/1/2025
Solicitation Type

American Diabetes Association (ADA): 2025 Pathway to Stop Diabetes

Request Ticket // Limit: 2* // Tickets Available: 1

Basic through Pre-clinical Research Studies // Limit: 1 // Tickets Available: 1

Clinical through Public Health Research // Limit: 1 // Tickets Available: 0
E. Lee (Engineering)

ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics.

Examples of basic through preclinical research studies (for nomination #1) include:

  • Innovative mechanistic studies on fundamental or new aspects of biology
  • Novel insights derived from data science using AI/Machine Learning
  • Development of new technologies, devices, and/or experimental approaches
  • Identification and validation of novel and unique therapeutic targets 


Examples of clinical through public health research (for nomination #2) include:

  • Clinical experimental medicine studies
  • Identification and validation of novel biomarkers
  • Health services research
  • Behavioral research
  • Population epidemiology
  • Health economics research
  • Patient preference / Quality of Life
  • Dissemination and implementation science
  • Health Care system-based interventions

     

Eligibility

Accelerator Award Eligibility

  • Applicants must hold independent faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K or R awards, including an initial NIH R01) but must not have applied for, or received, an NIH R01 renewal or a second R01 award.
  • Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
  • Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full- time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission.
  • Applications are open to individuals with current research positions at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
  • To assure continued excellence and diversity among applicants and awardees, the Association welcomes applications from all qualified individuals and strongly encourages applications from persons with diverse backgrounds, including minority groups that are underrepresented in biomedical research.
  • Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission.

Initiator Award Eligibility

  • Applicants must currently be in research training positions (i.e. post-doctoral fellowships, research fellowships) and can have no more than seven (7) years of training since their doctoral degree.
  • Initiator award recipients cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency).
  • Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full- time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission.
  • Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
  • Applicant fellowship positions must be at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
  • To assure continued excellence and diversity among applicants and awardees, the Association welcomes applications from all qualified individuals and strongly encourages applications from persons with diverse backgrounds, including minority groups that are underrepresented in biomedical research.
  • Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission
Funding Type
Internal Deadline
External Deadline
7/23/2025
Solicitation Type

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) - June 2025 Deadline

No Applicants // Limit: 4* (see below) // Tickets Available: 4

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 1

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct, and each is from a different candidate.

NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. An individual may not have two or more competing NIH career development applications pending review concurrently. In addition, NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review. (See NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."


 

Funding Type
Internal Deadline
External Deadline
6/16/2025
Solicitation Type